Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-11-15

Clinical Trial Update: Prophylactic Injection Therapy Reduces Recurrent Bleeding In Forrest Type IIb Duodenal Ulcers [NA]

View source ↗

Summary

A completed clinical trial reports that prophylactic injection therapy reduces recurrent bleeding in Forrest type IIb duodenal ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Bakirkoy Dr. Sadi Konuk Research and Training Hospital | Conditions: Duodenal Ulcer Bleeding | NA | Status: COMPLETED